top of page
Sneezing

Rebound COVID-19

We are now enrolling for a clinical trial evaluating the effectiveness of an oral treatment on individuals with rebound COVID-19.

A small number of people who have COVID-19 experience a return of signs/symptoms after initially feeling better, including those that have received treatment.

​

We have partnered with a sponsor to evaluate the effectiveness of an oral treatment on high-risk individuals who are experiencing rebound COVID-19 symptoms after initial treatment.

If you are interested in participating in this study or have questions about your eligibility, perform a self-check below and request a phone screen.

Download Study Flyer

Participant Enrollment Criteria

  • 12 years of age or older

  • Previous infection of COVID-19 with symptom alleviation followed by a worsening of signs/symptoms after completing a COVID-19 treatment.

  • One or more underlying medical condition associated with an increased risk of developing severe illness from COVID-19.

  • Additional criteria may apply


Participants Will Receive

  • Receive access to study related medical equipment and care


  • Receive compensation up to $820 and travel reimbursment.

Location and Time

​

  • All appointments are located at Eastside Research Associates in Redmond, WA

  • 8 in-clinic visits over the course of 24 weeks.

(425) 869-6828
info@eastsideresearch.com

Join our patient list for future studies.

Please fill out the following form to join our patient list for current and future studies. A member of our study recruitment team will receive your information and reach out to you within one business day.

bottom of page